Home/Filings/4/0001209191-23-050185
4//SEC Filing

Chaubey Alka 4

Accession 0001209191-23-050185

CIK 0001411690other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 5:26 PM ET

Size

10.7 KB

Accession

0001209191-23-050185

Insider Transaction Report

Form 4
Period: 2023-09-18
Chaubey Alka
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-09-18+20,000144,794 total
  • Award

    Stock Option (Right to Buy)

    2023-09-18+40,00040,000 total
    Exercise: $3.00Exp: 2033-09-17Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
  • [F2]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date.

Issuer

Bionano Genomics, Inc.

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001821605

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 5:26 PM ET
Size
10.7 KB